% | $
Quotes you view appear here for quick access.

Cardica Inc. Message Board

  • getitdone111 getitdone111 May 24, 2013 7:56 AM Flag

    I believe the contrcat that ISRG has with CRDC expires in Aug2013

    If I remember correctly at that point in time ISRG, unless signing another deal, no longer obtains rights pertaining to new stapling product patents. Could this mean there is potential for another deal at the end of the summer? Could be another cash boost.....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You are correct in that it was a 3 year deal initiated in august of 2010, which is coming to an end this august. Don't know what that means in terms of the microcutter development on the divinci.

      Sentiment: Strong Buy

      • 1 Reply to biotechbeagle
      • andersongordon May 24, 2013 9:13 AM Flag

        Speculative, but ISRG has gone ahead with the convetional perpendicular stapling technology and introduced more articulation and assisted stapling force---sort of like power assisted brakes. They do not have a continuous stapling solution (very valuable), nor do they have a way to reduce the size trocar needed to handle the perpendicular stapling technology. They are moving at a snails pace, possibly because that is driven by the need to have NO failures. Possibly because they are keeping their options open to switch technologies if Cardica's technology proves the solution to size and multiple staplings and the market (surgeons) adopt it as the best and standard for stapling. I think the latter scenario is the greater probability. If ISRG follows historical patterns, expect them to keep Cardica as an option but they may have to pay a lot more for their option if the 510k submittal looks promising.


2.64+0.07(+2.72%)May 27 3:59 PMEDT